Hypertension as cardiovascular risk factor in chronic kidney disease

M Burnier, A Damianaki - Circulation research, 2023 - Am Heart Assoc
Hypertension is the leading modifiable cause of premature death and hence one of the
global targets of World Health Organization for prevention. Hypertension also affects the …

Measurement of blood pressure in humans: a scientific statement from the American Heart Association

P Muntner, D Shimbo, RM Carey, JB Charleston… - …, 2019 - Am Heart Assoc
The accurate measurement of blood pressure (BP) is essential for the diagnosis and
management of hypertension. This article provides an updated American Heart Association …

[HTML][HTML] 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension

TD Wang, CE Chiang, TH Chao, HM Cheng… - Acta Cardiologica …, 2022 - ncbi.nlm.nih.gov
Hypertension is the most important modifiable cause of cardiovascular (CV) disease and all-
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …

Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal …

PA Sarafidis, A Persu, R Agarwal… - Nephrology dialysis …, 2017 - academic.oup.com
In patients with end-stage renal disease (ESRD) treated with haemodialysis or peritoneal
dialysis, hypertension is common and often poorly controlled. Blood pressure (BP) …

Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage

PE Drawz, AB Alper, AH Anderson… - Clinical Journal of the …, 2016 - journals.lww.com
Results The percentages of participants with controlled BP, white-coat, masked, and
sustained hypertension were 49.3%, 4.1%, 27.8%, and 18.8%, respectively. Compared with …

[HTML][HTML] 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension

CE Chiang, TD Wang, KC Ueng, TH Lin, HI Yeh… - Journal of the Chinese …, 2015 - Elsevier
It has been almost 5 years since the publication of the 2010 hypertension guidelines of the
Taiwan Society of Cardiology (TSOC). There is new evidence regarding the management of …

Prevalence of white-coat and masked hypertension in national and international registries

M Gorostidi, E Vinyoles, JR Banegas… - Hypertension …, 2015 - nature.com
In the past two decades, techniques for the measurement of blood pressure outside the
medical setting have unmasked highly prevalent situations. A significant proportion of …

Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions

J Peacock, KM Diaz, AJ Viera, JE Schwartz… - Journal of human …, 2014 - nature.com
Abstract 'Masked hypertension'is defined as having non-elevated clinic blood pressure (BP)
with elevated out-of-clinic average BP, typically determined by ambulatory BP monitoring …

Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients

PA Sarafidis, LM Ruilope, C Loutradis… - Journal of …, 2018 - journals.lww.com
Objective: Increased BP-variability predicts cardiovascular morbidity and mortality in
hypertensives. This study aimed to examine short-term BP-variability according to renal …

Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective …

R Minutolo, FB Gabbai, R Agarwal, P Chiodini… - American journal of …, 2014 - Elsevier
Background We investigated the effect of having clinic and/or ambulatory blood pressures
(BPs) not at goal on cardiorenal risk in patients with non− dialysis-dependent chronic kidney …